Snowflake (SNOW) director Slootman exercises options and sells 144,650 shares
Rhea-AI Filing Summary
Snowflake Inc. director Frank Slootman reported a set of option exercises and share sales in Snowflake common stock. He exercised stock options covering 144,650 shares at an exercise price of $8.88 per share, converting a derivative position into common shares.
On the same date, he sold a total of 144,650 shares of common stock in open-market transactions at weighted-average prices of $175.382 and $176.296 per share. The filing states these transactions were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on September 19, 2025, indicating they were scheduled in advance rather than timed discretionarily.
The filing also notes several indirect holdings in Snowflake common stock held through multiple family and grantor retained annuity trusts for which Slootman or his spouse serves as trustee, as well as that the exercised stock option was fully vested and carries an expiration date in 2029.
Positive
- None.
Negative
- None.
Insights
Slootman executed a planned option exercise and matched share sale under a 10b5-1 plan, a largely routine liquidity event.
The filing shows Frank Slootman exercised stock options for 144,650 Snowflake common shares at an exercise price of $8.88 per share, then sold the same number of shares in open-market trades around $175-177. This converts a derivative compensation award into cash.
The net result is a reduction in his direct share position, while the derivativeSummary indicates no remaining position in that particular option grant, which was fully vested and expires in May 2029. Several indirect holdings remain in family and grantor retained annuity trusts, where he or his spouse is trustee.
A key contextual detail is that these trades were made under a pre-arranged Rule 10b5-1 trading plan adopted on September 19, 2025. Such plans are established in advance and can signal that the timing of sales is more administrative than opportunistic, so the informational impact for investors is limited.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 144,650 | $0.00 | -- |
| Exercise | Common Stock | 144,650 | $8.88 | $1.28M |
| Sale | Common Stock | 134,378 | $175.382 | $23.57M |
| Sale | Common Stock | 10,272 | $176.296 | $1.81M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The exercise and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. Includes shares to be issued in connection with the vesting of one or more restricted stock units. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $175.000 to $175.990, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $176.000 to $176.860, inclusive. The shares are held by the Slootman Grandchildren's Trust dated 7/28/2022 for which the Reporting Person is a trustee. The shares are held by the Slootman 2023 Children's Trust dated 9/25/2023 for which the Reporting Person is a trustee. The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person is the trustee. The shares are held by the B. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person's spouse is the trustee. The stock option is fully vested.